Colcrys 01
Colcrys
Product Images NDC 64764-119
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colcrys (NDC 64764-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Colcrys 02
The text shows a graph displaying the percentage of patient improvement according to different dosages of medication. The medications compared are COLCRYS in both low-dose (1.8 mg) and high-dose (4.8 mg) and placebo. The X-axis shows the numbers ranging from 50 to 2100 and the Y-axis displays the percentages ranging from 0 to 100. The percentage of patient improvement ranges from 40.0% to 100.0% with the highest rate shown for COLCRYS Low-dose (1.8 mg).*
Colcrys 03
This is a prescription medication distributed by Takeda Pharmaceuticals America, Inc. It is a tablet containing 0.6 mg of Colchicine, USP. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and should be kept in a tight, light-resistant container. The package insert should be consulted for full prescribing information. The tablet itself is debossed with the letters AR 374.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
